Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 28 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

29%

8 trials in Phase 3/4

Results Transparency

8%

1 of 13 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (12)
P 3 (2)
P 4 (6)

Trial Status

Completed13
Unknown9
Enrolling By Invitation2
Recruiting2
Not Yet Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (28)

Showing 20 of 20 trials
NCT07151885Not ApplicableRecruiting

The Diagnostic Value of Subharmonic Imaging Technology Combined With Liver Stiffness and Platelet Count for High-risk Esophageal and Gastric Varices in Patients With Liver Cirrhosis

NCT07521332Phase 4Recruiting

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

NCT07248722Not ApplicableEnrolling By InvitationPrimary

Pantoprazole After Prophylactic Endoscopic Variceal Treatment

NCT07478770CompletedPrimary

Study on Portal Vein Pressure Gradient Measurement Under Endoscopic Ultrasound Guidance for Gastric Fundal Varices

NCT06863519Enrolling By InvitationPrimary

Evaluation of Endoscopic Treatment Effect Based on HVPG

NCT04044248Completed

TIPS Plus Transvenous Obliteration for Gastric Varices

NCT03130127Not ApplicableNot Yet Recruiting

Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis

NCT05978752Not ApplicableUnknownPrimary

Clinical Study on Endoscopic Management of GOV1 Esophagogastric Varices

NCT04976543Phase 4Completed

Safety of Anticoagulant Therapy After Endoscopic Treatment

NCT05331768Not ApplicableCompletedPrimary

Comparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin Therapy

NCT04823780Completed

The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis

NCT05055713Not ApplicableUnknown

A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism

NCT04210297CompletedPrimary

Development and Validation of an Noninvasive Model for Predicting High Risk Esophageal Varices in Cirrhosis

NCT02593799Completed

Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study

NCT02991612Not ApplicableCompleted

Rifaximin in Patients With Gastroesophageal Variceal Bleeding

NCT02504723Phase 4CompletedPrimary

Carvedilol as an Adjunct to Endoscopic Cyanoacrylate Injection for Secondary Prophylaxis of Gastric Variceal Bleeding

NCT03244332Not ApplicableCompletedPrimary

HEMOCC Study. Hemostasis in Cirrhotic Children.

NCT00475592Not ApplicableWithdrawnPrimary

Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy

NCT00006398Phase 3CompletedPrimary

Prevention of Esophageal Varices by Beta-Adrenergic Blockers

NCT02719119Not ApplicableUnknownPrimary

Trial of Monthly Versus Bi-weekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding

Scroll to load more

Research Network

Activity Timeline